Actively Recruiting
Virtual Ward for Early Discharge in Patients Receiving Inpatient Care
Led by Erasmus Medical Center · Updated on 2026-02-17
306
Participants Needed
1
Research Sites
193 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates the feasibility of providing hospital-level care at home for eligible patients through a Virtual Ward. Patients are discharged early from the hospital and monitored remotely using digital vital sign monitoring and anamnesis questionnaires. The primary aim is to determine if at least 30% of eligible patients can be safely and successfully transferred to the Virtual Ward under current Dutch healthcare conditions.
CONDITIONS
Official Title
Virtual Ward for Early Discharge in Patients Receiving Inpatient Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (≥18 years old).
- Currently hospitalized and eligible for early discharge according to clinical judgment.
- Ability to provide written informed consent.
- Access to a smartphone or tablet with internet connection.
- Patient is capable of using the Digizorg app or has support from a caregiver who can assist.
- Suitable home situation for Virtual Ward care (e.g., safe environment, necessary utilities available).
- Enrollment in one of the predefined Virtual Ward care pathways
You will not qualify if you...
- Patients requiring continuous hospital-based monitoring or interventions that cannot be safely delivered at home.
- Patients who are hemodynamically unstable or require oxygen therapy >5 liters/minute at the time of discharge.
- Patients unable or unwilling to comply with home monitoring procedures.
- Patients with significant cognitive impairment without adequate caregiver support.
- Patients with a life expectancy less than 30 days, as assessed by the treating physician.
- Patients participating in another interventional clinical trial that could interfere with the Virtual Ward protocol.
- Any other condition that, in the opinion of the treating physician, would make participation unsafe or infeasible.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Erasmus Medical Center
Rotterdam, Netherlands
Actively Recruiting
Research Team
M
Michael C. van Herwerden, MD
CONTACT
C
Cox van de Weg, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here